格隆汇1月29日丨上海医药(601607.SH)公布,公司下属正大青春宝药业有限公司(简称“青春宝”)自主研发的“芪苓颗粒”(称“该项目”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,芪苓颗粒处方源自杭州市中医院的临床验方。人用经验研究表明本品可缓解患者持续的关节肿痛症状,减少痛风急性发作次数;药效学试验表明本品与降尿酸化学药物联用可增强降尿酸效果,同时具有减轻肾脏病理损伤、保护...
Source Link格隆汇1月29日丨上海医药(601607.SH)公布,公司下属正大青春宝药业有限公司(简称“青春宝”)自主研发的“芪苓颗粒”(称“该项目”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,芪苓颗粒处方源自杭州市中医院的临床验方。人用经验研究表明本品可缓解患者持续的关节肿痛症状,减少痛风急性发作次数;药效学试验表明本品与降尿酸化学药物联用可增强降尿酸效果,同时具有减轻肾脏病理损伤、保护...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.